Samsung Biologics splits biosimilar business to boost CDMO, investment flexibility
Spin-off aims to sharpen operational focus, build client trust, enhance shareholder value
Samsung Biologics, the biotech arm of Samsung Group, announced Thursday that it will spin off its biosimilar operations into a new holding company, separating them from its contract development and manufacturing organization business to sharpen the strategic focus of each unit.
Through the structural realignment, Samsung Biologics will concentrate solely on its CDMO business, while the newly created holding company, tentatively called Samsung Epis Holdings, will oversee the biosimilar unit Samsung Bioepis. Kim Kyung-ah, CEO of Samsung Bioepis, will concurrently serve as CEO of the new holding company.
Samsung Bioepis was established in 2012 as a joint venture between Samsung Biologics and US-based Biogen, with Samsung initially holding an 85 percent stake. In 2022, Samsung Biologics acquired Biogen's remaining shares for $2.3 billion.
'This split reflects our decision to enhance competitiveness by responding swiftly to global changes and sharpening strategic focus,' said Samsung Biologics CEO John Rim. 'Both entities will accelerate their growth and are well-positioned to establish themselves as global leaders in biopharma.'
Samsung Biologics clarified that the creation of Samsung Epis Holdings through the spin-off bears no relation to the governance structure of Samsung Group.
The separation also aims to address concerns from CDMO clients regarding the in-house biosimilar unit. The dual-track model had raised conflict-of-interest concerns, particularly related to potential technology leakage.
'We've invested significant time and resources to ease these concerns, yet it's realistically difficult to eliminate all worries across our client base,' said Ryu Seung-ho, executive vice president of Samsung Biologics, at a press conference on Thursday.
'This restructuring will further allow each business to be properly valued in the market and give shareholders more flexibility to invest based on their own strategies," he added.
Under the deal, shareholders will receive shares in both companies based on current book values — approximately 0.65 shares in Samsung Biologics and 0.35 shares in Samsung Epis Holdings for each share held.
With the restructuring expected to fuel focused growth, both entities have outlined distinct long-term goals.
Samsung Biologics will double down on its ambition to become a global top-tier CDMO by investing in three key areas: expanding production capacity, diversifying its service portfolio, and widening its international footprint. New initiatives will target next-generation biomanufacturing technologies, including antibody-drug conjugates or ADCs, adeno-associated viruses or AAVs, and pre-filled syringes.
Samsung Epis Holdings will focus on expanding Samsung Bioepis's biosimilar portfolio to over 20 products, while also developing platform technologies and exploring investment opportunities in emerging technologies and global markets.
'Samsung Epis Holdings plans to establish new subsidiaries in addition to managing the existing Samsung Bioepis,' said Kim Hyoung-joon, vice president of Samsung Bioepis, at the press conference.
'These new entities will focus on developing platform technologies for future growth. We also aim to generate revenue through investments in domestic and global companies,' he added.
Regarding the upcoming procedures, the company will submit a registration statement on July 29, followed by a shareholder meeting for approval on Sept. 16.
Upon completion of the spin-off, effective Oct. 1, Samsung Epis Holdings will make Samsung Bioepis its wholly owned subsidiary. Both Samsung Biologics and Samsung Epis Holdings are scheduled to be relisted on Oct. 29.
Trading of Samsung Biologics shares will be temporarily suspended from Sept. 29 through Oct. 28.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
4 hours ago
- Korea Herald
Trump's 50% steel tariff deals blow to Korean exporters
New US levy threatens 13% of Korea's steel exports, prompting emergency talks in Seoul In yet another tariff storm last week, US President Donald Trump shocked the world once more with plans to double tariffs on imported steel and aluminum from 25 percent to 50 percent, starting Wednesday. Speaking from a US Steel mill in the Pittsburgh suburbs, Trump described the move as a deal that would 'secure' the American steel industry, one that 'nobody's going to get around.' The tariff escalation is set to deliver another major blow to Korean exporters, the fourth-largest steel supplier to the US. In 2024, exports to the US accounted for 13 percent of Korea's total steel exports. 'At a time when exports to the US are barely holding up following the 25 percent tariff, an additional 25 percent will severely undermine the competitiveness of Korean companies,' said an industry insider. In response, Korean trade officials and steelmakers, including Posco Holdings and Hyundai Steel, gathered Monday for an emergency meeting convened by the Ministry of Trade, Industry and Energy in Seoul to assess the fallout. The agenda centered on evaluating the potential impact of the tariff hike on the industry and formulating future response strategies. While closely monitoring the situation through its networks with US diplomatic offices and the US subsidiaries of Korean companies, the ministry has pledged to implement swift responses to 'minimize' the impact on Korea's steel sector. Some analysts, however, suggest the damage may be limited. According to a Seoul-based market researcher at Daol Investment & Securities, even after the initial 25 percent tariff, US prices for hot-rolled steel remained high. 'The full impact of the new hike depends on how much US steel prices rise in response,' the researcher said. That, in turn, may increase the competitive edge of companies like Hyundai Steel. The company is committed to a $5.8 billion investment plan to build an electric arc furnace-based integrated steel mill in Louisiana by 2029, in partnership with Posco Group. The tariff hike comes amid the US push to bolster its domestic steel industry, which constitutes the backbone of the nation, according to Trump. Trump recently endorsed US Steel's $14 billion acquisition by Japan-based Nippon Steel, a deal he had previously opposed on national security grounds. He said the partnership would create and save more than 100,000 jobs while keeping the American steelmaker under US control, though few details have been disclosed. Although the Court of International Trade ruled last week against Trump's tariffs under the International Emergency Economic Powers Act, potentially hindering his use of punitive levies, it has no bearing on steel and aluminum tariffs. Those instead fall under Section 232 of the Trade Expansion Act, which authorizes tariffs on national security grounds.
Korea Herald
7 hours ago
- Korea Herald
K-beauty wears US crown — Can it survive tariff test?
A resounding win, but hurdles remain as K-beauty's US lead signals deeper push into mainstream It's now clear that Korean beauty has far outgrown its modest local beginnings. Last year was truly a banner year for the industry, with cosmetics exports surging 20.3 percent to $10.2 billion, ranking third globally behind the US ($11.19 billion) and France ($23.26 billion), according to the Ministry of Food and Drug Safety. Zooming in on US-bound exports last year, Korea's stature continues to rise: The country is not only in the top three in global exports, it ranks first in the world's largest consumer market, eclipsing former leader France. To the top: US breakthrough K-beauty's success formula, rooted in the global K-content wave and lab-based innovation, has worked its magic worldwide, but it's the affordability and e-commerce factors that have propelled K-beauty onto mainstream American shelves. The online retail platform Amazon, unsurprisingly, is the prime stage for K-beauty brands, a gateway essential to nationwide popularity in the US. 'Many leading K-beauty brands have found success entering the US market through Amazon,' noted a Seoul-based cosmetics researcher, adding that their strong sales, fueled by K-beauty's competitive pricing, have only further driven demand. Amazon reported that K-beauty sellers' net sales on its US platform jumped roughly 170 percent on-year last year, with the number of brands climbing to 230, a 1.4-fold increase over the past three years. Success in online sales creates synergies with social media platforms like TikTok and Instagram, where K-beauty builds familiarity and trust with consumers through viral videos. So much so that TikTok's e-commerce channel, TikTok Shop, has become a new space where brands like Medipeel and Anua now hold top spots. Outside the digital realm, Korean beauty has moved into a new phase of visibility, now stocked in major beauty retailers like Sephora and Ulta Beauty, and supermarket chains such as Walmart and Target. Widespread retail contact, however, is not enough to sustain the K-beauty hype if the products fail to deliver on their promised efficacy. 'K-beauty's ascent owes much to its deep understanding of American consumers and its agility in meeting their needs,' explained Kim Ju-duck, professor in the beauty industry department at Sungshin Women's University. 'It has been quick to deliver localized, high-quality products tailored to American preferences and skin types, while putting emphasis on clean formulations that resonate with sustainability-conscious consumers.' Famous examples include TirTir, whose 30-shade cushion compact appealed to a diverse range of skin tones, topping Amazon's US beauty sales last year. In skincare, Medicube has gained popularity for its collagen-boosting properties, while brands such as Cosrx and Anua stand out for star ingredients like snail secretion and heartleaf extract. Driving this growth in part are original design manufacturers, according to Kim, whose advanced development and production capabilities have enabled smaller Korean brands to scale rapidly. This marks a subtle yet profound shift in consumer behavior from brand loyalty to a product-first mindset, one industry observer noted. Regardless of brand size, more consumers, especially younger generations, are weighing product quality and price above all. Korea's top two ODMs, Kolmar Korea and Cosmax, both posted record-high sales last year at 2.45 trillion won and 2.16 trillion won, respectively. Storied brands and contract manufacturers, which handle the bulk of production for smaller K-beauty brands, also remain well-prepared to meet US regulations, including stricter FDA registration, product listing and labeling requirements under the Modernization of Cosmetics Regulation Act. 'We have a dedicated team that monitors US regulations, including MoCRA and the FDA's requirements for over-the-counter drugs like sunscreens, to ensure compliance,' said a Cosmax official. At the top: US hurdles K-beauty's hard-won rise to prominence faces a looming challenge: a delayed 25 percent tariff set to hit on July 8, adding to the minimum 10 percent tariff already in place. In a bid to offset the impact, some firms are leveraging their existing capabilities, while others are eyeing market entry. Kolmar Korea is ramping up its US operations, with a second facility entering pilot operations in the second quarter of this year, complementing its existing factory in Pennsylvania. 'With the Trump administration's tariffs in play, we're seeing a rise in domestic brand inquiries for US-based production," a Kolmar official said. Once the second plant comes online, Kolmar Korea expects its local annual production capacity for sunscreens and basic skincare to nearly double from the current 180 million. Cosmax projected its sunscreen production in Korea and the US will more than triple this year, as four times as many clients plan to enter the US OTC sunscreen market. Cosmax's facility in New Jersey produces around 280 million units annually, accounting for 10 percent of the company's total production. The move coincides with a tariff scare that, in April, sent US consumers into a buying spree for Korean sunscreens prized for their superior UV protection and seamless compatibility with layered makeup. South Korea's top two beauty giants, Amorepacific and LG Household & Health Care, are also stepping up their US operations. LG H&H announced in April a $130 million paid-in capital increase for its North American subsidiary in order to expand its product lineup and boost marketing initiatives. Amorepacific hinted at building its own US manufacturing facilities. In April, CEO Kim Seung-hwan told Bloomberg TV the company plans to invest in US logistics and modular production infrastructure within the next three to five years. Though the tariff situation may seem dire, some industry insiders are more concerned about the strong won against the dollar, which could drive up the prices of Korean imports in the US market. 'Tariffs strike far and wide, not just Korea, and for companies heavily dependent on exports, the won-dollar exchange rate could prove even more critical,' said one insider on condition of anonymity. They went on to describe a new chapter in which technological prowess will shape success in an increasingly personalized and segmented market for years to come: 'In fact, consumers' love for K-beauty is no longer about price alone." K-beauty brands are hardly running behind as they pursue rapid innovation in their products. At this year's CES in January, for instance, beauty powerhouses like Amorepacific, Kolmar Korea and APR showcased next-generation beauty tech, including AI-powered devices, as they charge forward into the tech-infused future.
Korea Herald
a day ago
- Korea Herald
Sands China eyes growing Korean market with opening of Londoner Grand in Macao
Sands China, a Macao-based developer, owner and operator of integrated resorts and casinos, is preparing for the June 8 opening of its newly refurbished Londoner Grand, a key component of the company's ongoing $1.2 billion transformation of the integrated resort The Londoner Macao. The revamped property aims to appeal to the growing number of premium Korean travelers visiting Macao. In an exclusive interview with The Korea Herald ahead of a showcase event in Seoul on Thursday, Wilfred Wong, executive vice chairperson of Sands China, discussed the company's focus on the Korean market, which has seen rapid growth in recent years. Wong emphasized that Sands China is committed to offering a more tailored experience for Korean guests, who increasingly seek integrated and luxury travel offerings. 'We look at Korea as a very strong market. And if you look at the visitor number in the first quarter, Korean visitors' growth rate is over 30 percent (on-year),' Wong said. 'That's why we have always put a lot of emphasis on the Korean market.' The Londoner Grand is a focal point for Sands China's efforts to cater to Korean visitors, he added. In addition to Korean-speaking concierge staff, the property also features specialized dining options designed to appeal to Korean tastes. The newly introduced North Palace restaurant, an upgraded version of the popular North in The Venetian Macao, serves Northern Chinese cuisine, a favorite of Korean guests. 'Koreans have a very strong taste. That's why North is one of their favorites. With North Palace, we've made it bigger, more beautiful, with a variety of dishes like Peking duck and roast lamb,' Wong said. As the company sees growing demand from high-value travelers, the property's newly designed rooms and suites reflect Sands China's strategy to provide premium accommodations. With 2,405 rooms across 18 different types, the Londoner Grand aims to deliver a curated and exclusive experience for guests seeking personalized luxury. 'We have ultraluxury room types for the really big spenders, along with family rooms and suites. It's a more refined offering compared to what we had before,' Wong explained. Wong also noted what makes Macao an appealing destination for Korean tourists. The city's compact size allows visitors to explore historical sites and modern attractions within a short distance, making it convenient for travelers who want to maximize their time. 'Macao offers different experiences within a small area. In Seoul, I travel for an hour or more to get to places, but in Macao, anything beyond a 20-minute car ride is far,' Wong said. The Londoner Grand provide a one-stop experience with shopping, dining and entertainment all within one property, he noted, adding that convenience is increasingly attractive to younger Korean travelers, who want everything in one place. Also to align the growing global demand for responsible tourism, Wong said, the company has made significant strides in incorporating eco-friendly practices, such as energy-saving initiatives and waste reduction programs. Sands China has been included in the Dow Jones Sustainability Indices and earned a top 1 percent ranking in the 2024 S&P Global Sustainability Yearbook. Looking ahead, Wong is optimistic about the future of the Londoner Grand as a world-class destination for premium travelers, particularly as Sands China continues to cater to evolving guest preferences. 'Our vision is simple: to offer world-class experiences that travelers will remember and return for,' Wong said.
